Intended for the in vitro quantitative determination of Low Density Lipoprotein Cholesterol in human serum or plasma. 1120 tests.
The reagents can assist in the diagnosis and treatment of patients at risk of developing coronary heart disease. Elevated LDL cholesterol is the primary target of cholesterol-lowering therapy.
Diazyme's LDL-Cholesterol Assay is a direct dual liquid stable reagent system. Reagent transfer is eliminated for most chemistry systems with a choice of convenient instrument specific packaging options including Roche Hitachi 917 series, Beckman AU (400/600/640/680), Beckman Synchron CX, LX and DXC. The assay utilizes Diazyme's proprietary PVSPEGME coupled technology which provides outstanding performance. The assay features a linear range of up to 250 mg/dL, intra and inter %CV values < 5.0 % and less than 10% interference from triglycerides to 1000 mg/dL, ascorbic acid to 10 mmol/L, bilirubin to 40 mg/ dL, bilirubin conjugate to 30 mg/dL, hemoglobin to 1000 mg/dL.